BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3055538)

  • 1. A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients.
    Claas FH; Gijbels Y; van der Velden-de Munck JJ; de Waal LP; D'Amaro J; Hendriks GF; Persijn GG; van Rood JJ
    Transplant Proc; 1988 Oct; 20(5):947-8. PubMed ID: 3055538
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of cross-match negative HLA-A and/or -B mismatched donors for highly sensitized patients.
    Claas FH; Gijbels Y; von Veen A; de Waal LP; D'Amaro J; Persijn GG; van Rood JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):665-6. PubMed ID: 2650216
    [No Abstract]   [Full Text] [Related]  

  • 3. Cadaveric kidneys should be allocated according to the HLA match.
    Opelz G; Wujciak T
    Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235
    [No Abstract]   [Full Text] [Related]  

  • 4. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
    Cicciarelli J; Terasaki P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
    [No Abstract]   [Full Text] [Related]  

  • 6. Negative cross-match selection of HLA-DR compatible kidneys for highly sensitised patients.
    Claas FH
    Immunol Lett; 1991 Jul; 29(1-2):61-4. PubMed ID: 1916926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
    Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
    Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposed HLA matching scheme for improved cadaveric kidney allocation.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S
    Transplant Proc; 1995 Feb; 27(1):61-3. PubMed ID: 7879117
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
    Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperimmunized patients do not need to wait for an HLA identical donor.
    Claas FH; van Leeuwen A; van Rood JJ
    Tissue Antigens; 1989 Jul; 34(1):23-9. PubMed ID: 2683206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 15. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I peptides involved in the indirect pathway of allorecognition.
    Takemoto SK; Cecka JM; Gjertson DW; Terasaki PI
    Transplant Proc; 1999; 31(1-2):781. PubMed ID: 10083332
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants.
    Hors J; Busson M; Bouteiller AM; Raffoux C; Betuel H; Fauchet R; Tongio MM; Mercier P; Lepetit JC; Dausset J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HLA-A,B match of primary renal allografts subsequent to transplant failure.
    Sanfilippo F; Goeken N; Niblack G; Scornik J; Vaughn WK
    Transplant Proc; 1987 Feb; 19(1 Pt 1):669-71. PubMed ID: 3274835
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
    Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.